A
ARWR
Arrowhead Pharma
58.02
-0.34-0.58%After Hours: 58.33 +0.31 +0.53%18:20 10/23 EDT
OPEN/PREV CLOSE58.15/58.36
TODAY RANGE56.56-58.40
VOL871.82K
MARKET CAP8.20B
52 WEEK RANGE36.73-95.49
AVG VOL (3M)1.76M
% TURNOVER0.48%
TURNOVER--
P/E (TTM)-25.8983
% RANGE3.12%
EPS(TTM)-2.2403
P/E(FORWARD)-16.1061
P/B17.59
BVPS3.299
DIVIDEND--
P/S9.49
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP7.90B
SHARES OUTSTANDING141.25M
NEXT EARNINGS11/23-12/07
FREE FLOAT136.09M
LOT SIZE1
EX-DATE11/17/2011
News
Press Releases
Financial Reports
Profile
Seeking Alpha·2d ago
Ionis upgraded at BMO on Tryngolza adoption for severe hypertriglyceridemia
TipRanks·2d ago
Arrowhead Pharmaceuticals (ARWR) Gets a Buy from UBS
Benzinga·2d ago
Top 3 Health Care Stocks That Could Blast Off In October
Simply Wall St·2d ago
How Investors Are Reacting To Arrowhead Pharmaceuticals (ARWR) Brain Drug Trial Progress
Simply Wall St·3d ago
Arrowhead Pharmaceuticals (ARWR) In Focus As Brain Delivery Breakthrough Fuels Undervalued View
Simply Wall St·10/16 06:33
What Arrowhead Pharmaceuticals Doubters Missed
Dow Jones·10/15 22:39
Arrowhead Pharmaceuticals Is Maintained at Buy by Chardan Capital
Dow Jones·10/15 21:48
Arrowhead Pharmaceuticals Price Target Raised to $109.00/Share From $63.00 by UBS
Dow Jones·10/15 21:48
Arrowhead Pharmaceuticals Coverage Assumed by UBS at Buy
Seeking Alpha·10/15 12:38
Arrowhead Pharmaceuticals: ARO-MAPT Results Unlock A New Platform
TipRanks·10/15 11:37
Arrowhead Pharmaceuticals (ARWR) Gets a Buy from Piper Sandler
TipRanks·10/15 10:30
Wall Street Analysts Are Bullish on Top Healthcare Picks
Same Industry
Name/Symbol
Change%
Price